SEARCH

SEARCH BY CITATION

References

  • Cushman, M., Cornell, E.S., Howard, P.R., Bovill, E.G. & Tracy, R.P. (1995) Laboratory methods and quality assurance in the Cardiovascular Health Study. Clinical Chemistry, 41, 264270.
  • Cushman, M., Tsai, A.W., White, R.H., Heckbert, S.R., Rosamond, W.D., Enright, P. & Folsom, A.R. (2004) Deep vein thrombosis and pulmonary embolism in two cohorts: the Longitudinal Investigation of Thromboembolism Etiology. American Journal of Medicine, 117, 1925.
  • Dählback, B. & Villoutreix, B.O. (2005) The anticoagulant protein C pathway. FEBS Letters, 579, 33103316.
  • Esmon, C.T. (2006) The endothelial protein C receptor. Current Opinion in Hematology, 13, 382385.
  • Folsom, A.R., Wu, K.K., Rosamond, W.D., Sharrett, A.R. & Chambless, L.E. (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation, 96, 11021108.
  • Folsom, A.R., Cushman, M., Tsai, M.Y., Aleksic, N., Heckbert, S.R., Boland, L.L., Tsai, A.W., Yanez, N.D. & Rosamond, W.D. (2002a) A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood, 99, 27202725.
  • Folsom, A.R., Cushman, M., Tsai, M.Y., Heckbert, S.R. & Aleksic, N. (2002b) Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. American Journal of Hematology, 71, 285290.
  • Folsom, A.R., Aleksic, N., Wang, L., Cushman, M., Wu, K.K. & White, R.H. (2002c) Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 10181022.
  • Fried, L.P., Borhani, N.O., Enright, P., Furberg, C.D., Gardin, J.M., Kronmal, R.A., Kuller, L.H., Manolio, T.A., Mittelmark, M.B. & Newman, A. (1991) The Cardiovascular Health Study: design and rationale. Annals of Epidemiology, 1, 263276.
  • Ghosh, S., Pendurthi, U.R., Steinoe, A., Esmon, C.T. & Rao, L.V. (2007) Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. Journal of Biological Chemisty, 282, 1184911857.
  • López-Sagaseta, J., Montes, R., Puy, C., Díez, N., Fukudome, K. & Hermida, J. (2007) Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity. Journal of Thrombosis and Haemostasis, 5, 18171824.
  • Medina, P., Navarro, S., Estelles, A., Vaya, A., Woodhams, B., Mira, Y., Villa, P., Migaud-Fressart, M., Ferrando, F. & Aznar, J. (2004) Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk. Thrombosis and Haemostasis, 91, 905911.
  • Ohira, T., Cushman, M., Tsai, M.Y., Zhang, Y., Heckbert, S.R., Zakai, N.A., Rosamond, W.D. & Folsom, A.R. (2007) ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Journal of Thrombosis and Haemostasis, 5, 14551461.
  • Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 36983703.
  • De Ronde, H. & Bertina, R.M. (1994) Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thrombosis and Haemostasis, 72, 880886.
  • Saposnik, B., Reny, J.L., Gaussem, P., Emmerich, J., Aiach, M. & Gandrille, S. (2004) A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood, 103, 13111318.
  • The ARIC Investigators. (1989) The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. American Journal of Epidemiology, 129, 687702.
  • Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Polak, J.F. & Folsom, A.R. (2002a) Cardiovascular risk factors and venous thromboembolism incidence: the Longitudinal Investigation of Thromboembolism Etiology. Archives of Internal Medicine, 162, 11821189.
  • Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Tracy, R.P., Aleksic, N. & Folsom, A.R. (2002b) Coagulation factors, inflammation markers, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). American Journal of Medicine, 113, 636642.
  • Uitte de Willige, S., Van Marion, V., Rosendaal, F.R., Vos, H.L., De Visser, M.C. & Bertina, R.M. (2004) Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. Journal of Thrombosis and Haemostasis, 2, 13051310.
  • Van de Wouwer, M., Collen, D. & Conway, E.M. (2004) Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 13741383.